检索结果 - Xiaoping Dong
- Showing 1 - 7 results of 7
-
1
-
2
-
3
-
4
Neoadjuvant programmed cell death protein 1 inhibitors combined with chemotherapy in resectable non-small cell lung cancer: an open-label, multicenter, single-arm study 由 Hongtao Duan, Tianhu Wang, Zhilin Luo, Liping Tong, Xiaoping Dong, Yong Zhang, Muhammad Zubair Afzal, Pierpaolo Correale, Honggang Liu, Tao Jiang, Xiaolong Yan
出版 2021Artigo -
5
-
6
A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study) 由 Hongtao Duan, Tianhu Wang, Zhilin Luo, Xiaoyuan Wang, Honggang Liu, Liping Tong, Xiaoping Dong, Yong Zhang, Michele Valmasoni, Biniam Kidane, Khaldoun Almhanna, Ory Wiesel, Sainan Pang, Jianqun Ma, Xiaolong Yan
出版 2021Artigo -
7
Neoadjuvant Pembrolizumab and Chemotherapy in Resectable Esophageal Cancer: An Open-Label, Single-Arm Study (PEN-ICE) 由 Hongtao Duan, Changjian Shao, Minghong Pan, Honggang Liu, Xiaoping Dong, Yong Zhang, Liping Tong, Yingtong Feng, Yuanyuan Wang, Lu Wang, Neil B. Newman, Inderpal S. Sarkaria, John V. Reynolds, Francesco De Cobelli, Zhiqiang Ma, Tao Jiang, Xiaolong Yan
出版 2022Artigo
相关主题
Medicine
Biology
Breast cancer
Cancer
Chemotherapy
Internal medicine
Neoadjuvant therapy
Oncology
Chemistry
Esophageal cancer
Esophagectomy
Genetics
Immunotherapy
Rash
Surgery
Adverse effect
Antimicrobial
Antimicrobial peptides
Bacteria
Biochemistry
Biofilm
Biotechnology
Clade
Clinical endpoint
Clinical trial
Dental plaque
Dysphagia
Evolutionary biology
Ex vivo
Fusobacterium nucleatum